FINANCIAL ASSISTANCE PROGRAMS FOR PATIENTS

Eligible commercially insured patients may save on each Monthly or Quarterly prescription of AJOVY*

Patients should present this card to the pharmacist to determine their eligibility and savings.

*Out-of-pocket costs may vary based on insurance coverage. Exclusions and limitations apply. Please note, this offer is not available for patients eligible for Medicare, Medicaid, or any other public payer coverage. See full Terms and Conditions for eligibility and restrictions.

Patient Assistance Program

For patients who are uninsured or unable to afford AJOVY, the Teva Cares Foundation may be able to help.

Teva Cares is an independent, non-profit organization that provides AJOVY at no cost to eligible patients.^† To learn more visit TevaCares.org or call 1-877-237-4881

^†Patient must reside in the United States, meet insurance and income criteria, and have a valid prescription.

Contraindications: AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients. Reactions have included anaphylaxis and angioedema.

Hypersensitivity Reactions: Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria were reported with AJOVY in clinical trials. Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment. Most reactions were reported from within hours to one month after administration. Cases of anaphylaxis and angioedema have been reported in the postmarketing setting. If a hypersensitivity reaction occurs, consider discontinuing AJOVY and institute appropriate therapy.

Adverse Reactions: The most common adverse reactions in clinical trials (≥5% and greater than placebo) were injection site reactions.

AJOVY is indicated for the preventive treatment of migraine in adults.

Please see full Prescribing Information for AJOVY.